Report Overview:
Stomach cancer is the fifth most common cancer in the world
The Global Stomach Cancer and Gastric Cancer Drugs Market Size was estimated at USD 4454.45 million in 2023 and is projected to reach USD 9078.73 million by 2029, exhibiting a CAGR of 12.60% during the forecast period.
This report provides a deep insight into the global Stomach Cancer and Gastric Cancer Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Stomach Cancer and Gastric Cancer Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Stomach Cancer and Gastric Cancer Drugs market in any manner.
Global Stomach Cancer and Gastric Cancer Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ipsen Pharma
Merck & Co., Inc.
Bristol-Myers Squibb Company
Eli Lilly
Roche
Novartis AG
Bayer AG
Celltrion Inc.
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co., Ltd.
Market Segmentation (by Type)
Programmed Cell Death Protein 1 (PD-1) Inhibitors
Human Epidermal Growth Factor Receptor (HER2) Antagonists
Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
Others
Market Segmentation (by Application)
Hospitals
Clinics
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Stomach Cancer and Gastric Cancer Drugs Market
? Overview of the regional outlook of the Stomach Cancer and Gastric Cancer Drugs Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Stomach Cancer and Gastric Cancer Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Stomach Cancer and Gastric Cancer Drugs
1.2 Key Market Segments
1.2.1 Stomach Cancer and Gastric Cancer Drugs Segment by Type
1.2.2 Stomach Cancer and Gastric Cancer Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Stomach Cancer and Gastric Cancer Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Stomach Cancer and Gastric Cancer Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Stomach Cancer and Gastric Cancer Drugs Market Competitive Landscape
3.1 Global Stomach Cancer and Gastric Cancer Drugs Sales by Manufacturers (2019-2024)
3.2 Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Stomach Cancer and Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Stomach Cancer and Gastric Cancer Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Stomach Cancer and Gastric Cancer Drugs Sales Sites, Area Served, Product Type
3.6 Stomach Cancer and Gastric Cancer Drugs Market Competitive Situation and Trends
3.6.1 Stomach Cancer and Gastric Cancer Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Stomach Cancer and Gastric Cancer Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Stomach Cancer and Gastric Cancer Drugs Industry Chain Analysis
4.1 Stomach Cancer and Gastric Cancer Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Stomach Cancer and Gastric Cancer Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Stomach Cancer and Gastric Cancer Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Type (2019-2024)
6.3 Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Stomach Cancer and Gastric Cancer Drugs Price by Type (2019-2024)
7 Stomach Cancer and Gastric Cancer Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Stomach Cancer and Gastric Cancer Drugs Market Sales by Application (2019-2024)
7.3 Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Stomach Cancer and Gastric Cancer Drugs Sales Growth Rate by Application (2019-2024)
8 Stomach Cancer and Gastric Cancer Drugs Market Segmentation by Region
8.1 Global Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.1.1 Global Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.1.2 Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Stomach Cancer and Gastric Cancer Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Stomach Cancer and Gastric Cancer Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Stomach Cancer and Gastric Cancer Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ipsen Pharma
9.1.1 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Basic Information
9.1.2 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product Overview
9.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.1.4 Ipsen Pharma Business Overview
9.1.5 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
9.1.6 Ipsen Pharma Recent Developments
9.2 Merck and Co., Inc.
9.2.1 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.2.2 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.2.3 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.2.4 Merck and Co., Inc. Business Overview
9.2.5 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
9.2.6 Merck and Co., Inc. Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Basic Information
9.3.2 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product Overview
9.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.3.4 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Eli Lilly
9.4.1 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Basic Information
9.4.2 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product Overview
9.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.4.4 Eli Lilly Business Overview
9.4.5 Eli Lilly Recent Developments
9.5 Roche
9.5.1 Roche Stomach Cancer and Gastric Cancer Drugs Basic Information
9.5.2 Roche Stomach Cancer and Gastric Cancer Drugs Product Overview
9.5.3 Roche Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Novartis AG
9.6.1 Novartis AG Stomach Cancer and Gastric Cancer Drugs Basic Information
9.6.2 Novartis AG Stomach Cancer and Gastric Cancer Drugs Product Overview
9.6.3 Novartis AG Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.6.4 Novartis AG Business Overview
9.6.5 Novartis AG Recent Developments
9.7 Bayer AG
9.7.1 Bayer AG Stomach Cancer and Gastric Cancer Drugs Basic Information
9.7.2 Bayer AG Stomach Cancer and Gastric Cancer Drugs Product Overview
9.7.3 Bayer AG Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.7.4 Bayer AG Business Overview
9.7.5 Bayer AG Recent Developments
9.8 Celltrion Inc.
9.8.1 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.8.2 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.8.4 Celltrion Inc. Business Overview
9.8.5 Celltrion Inc. Recent Developments
9.9 TAIHO PHARMACEUTICAL CO., LTD.
9.9.1 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.9.2 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.9.4 TAIHO PHARMACEUTICAL CO., LTD. Business Overview
9.9.5 TAIHO PHARMACEUTICAL CO., LTD. Recent Developments
9.10 Jiangsu Hengrui Medicine Co., Ltd.
9.10.1 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.10.2 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.10.4 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
9.10.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
10 Stomach Cancer and Gastric Cancer Drugs Market Forecast by Region
10.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast
10.2 Global Stomach Cancer and Gastric Cancer Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Region
10.2.4 South America Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Stomach Cancer and Gastric Cancer Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Stomach Cancer and Gastric Cancer Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Stomach Cancer and Gastric Cancer Drugs by Type (2025-2030)
11.1.2 Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Stomach Cancer and Gastric Cancer Drugs by Type (2025-2030)
11.2 Global Stomach Cancer and Gastric Cancer Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Stomach Cancer and Gastric Cancer Drugs Market Size Comparison by Region (M USD)
Table 5. Global Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Stomach Cancer and Gastric Cancer Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Stomach Cancer and Gastric Cancer Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer and Gastric Cancer Drugs as of 2022)
Table 10. Global Market Stomach Cancer and Gastric Cancer Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Stomach Cancer and Gastric Cancer Drugs Sales Sites and Area Served
Table 12. Manufacturers Stomach Cancer and Gastric Cancer Drugs Product Type
Table 13. Global Stomach Cancer and Gastric Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Stomach Cancer and Gastric Cancer Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Stomach Cancer and Gastric Cancer Drugs Market Challenges
Table 22. Global Stomach Cancer and Gastric Cancer Drugs Sales by Type (Kilotons)
Table 23. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Type (M USD)
Table 24. Global Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Stomach Cancer and Gastric Cancer Drugs Market Size Share by Type (2019-2024)
Table 28. Global Stomach Cancer and Gastric Cancer Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) by Application
Table 30. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Application
Table 31. Global Stomach Cancer and Gastric Cancer Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Stomach Cancer and Gastric Cancer Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2019-2024)
Table 35. Global Stomach Cancer and Gastric Cancer Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Stomach Cancer and Gastric Cancer Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Stomach Cancer and Gastric Cancer Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Stomach Cancer and Gastric Cancer Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Stomach Cancer and Gastric Cancer Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Stomach Cancer and Gastric Cancer Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Stomach Cancer and Gastric Cancer Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 44. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 45. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ipsen Pharma Business Overview
Table 47. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
Table 48. Ipsen Pharma Recent Developments
Table 49. Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 50. Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 51. Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck and Co., Inc. Business Overview
Table 53. Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
Table 54. Merck and Co., Inc. Recent Developments
Table 55. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 56. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 57. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
Table 59. Bristol-Myers Squibb Company Business Overview
Table 60. Bristol-Myers Squibb Company Recent Developments
Table 61. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 62. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 63. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Recent Developments
Table 66. Roche Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 67. Roche Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 68. Roche Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Novartis AG Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 72. Novartis AG Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 73. Novartis AG Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Recent Developments
Table 76. Bayer AG Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 77. Bayer AG Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 78. Bayer AG Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Bayer AG Business Overview
Table 80. Bayer AG Recent Developments
Table 81. Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 82. Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 83. Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Celltrion Inc. Business Overview
Table 85. Celltrion Inc. Recent Developments
Table 86. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 87. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 88. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. TAIHO PHARMACEUTICAL CO., LTD. Business Overview
Table 90. TAIHO PHARMACEUTICAL CO., LTD. Recent Developments
Table 91. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Basic Information
Table 92. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product Overview
Table 93. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 95. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 96. Global Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Stomach Cancer and Gastric Cancer Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Stomach Cancer and Gastric Cancer Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Stomach Cancer and Gastric Cancer Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD), 2019-2030
Figure 5. Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Stomach Cancer and Gastric Cancer Drugs Market Size by Country (M USD)
Figure 11. Stomach Cancer and Gastric Cancer Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Stomach Cancer and Gastric Cancer Drugs Revenue Share by Manufacturers in 2023
Figure 13. Stomach Cancer and Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Stomach Cancer and Gastric Cancer Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Stomach Cancer and Gastric Cancer Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Type
Figure 18. Sales Market Share of Stomach Cancer and Gastric Cancer Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Stomach Cancer and Gastric Cancer Drugs by Type in 2023
Figure 20. Market Size Share of Stomach Cancer and Gastric Cancer Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Stomach Cancer and Gastric Cancer Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application
Figure 24. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Application in 2023
Figure 26. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2019-2024)
Figure 27. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application in 2023
Figure 28. Global Stomach Cancer and Gastric Cancer Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Stomach Cancer and Gastric Cancer Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Country in 2023
Figure 37. Germany Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Region in 2023
Figure 44. China Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Stomach Cancer and Gastric Cancer Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Stomach Cancer and Gastric Cancer Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Stomach Cancer and Gastric Cancer Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Stomach Cancer and Gastric Cancer Drugs Market Share Forecast by Application (2025-2030)
